William D. Waddill - Apr 15, 2024 Form 4 Insider Report for Turnstone Biologics Corp. (TSBX)

Role
Director
Signature
/s/ Venkat Ramanan, Attorney-in-Fact
Stock symbol
TSBX
Transactions as of
Apr 15, 2024
Transactions value $
$0
Form type
4
Date filed
4/16/2024, 05:38 PM
Previous filing
Mar 1, 2024
Next filing
Jul 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TSBX Stock Option (Right to Buy) Award $0 +25.5K $0.00 25.5K Apr 15, 2024 Common Stock 25.5K $2.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Thirty three and thirty three one hundreds percent (33.33%) (and thirty three and thirty four one hundreds percent (33.34%) for year three) of the shares subject to the option will vest in three (3) annual installments commencing on the first anniversary of the date of grant such that the option is fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date.